Sign In

Christoph Esslinger

CSO at Memo Therapeutics AG

Christoph Esslinger is a highly accomplished professional with a diverse educational background and extensive experience in the fields of research, biotechnology, and healthcare.

Christoph pursued his academic journey by obtaining a PhD at the prestigious Ludwig Institute for Cancer Research at Université de Lausanne, focusing on parasitology during his studies at Université Joseph Fourier (Grenoble I) and completing a Diploma/Masters in Biologie at the University of Stuttgart.

Throughout his career, Christoph has held key leadership roles in various organizations, including serving as the CEO of Memo Therapeutics, the Chief Technology Officer at CT Atlantic, the Director of Antibody Discovery at Neurimmune Therapeutics AG, a Group Leader at the University of Zurich in the Division of Psychiatry Research, and as a Postdoc at the Ludwig Institute for Cancer Research.

His professional journey showcases his expertise in antibody discovery, biotechnology, and pharmaceuticals, highlighting his commitment to advancing research and innovation in the healthcare industry.

Christoph Esslinger's contributions to the field have been significant, and his leadership roles have positioned him as a respected figure in the realms of biotechnology and healthcare innovation.

C
Add to my network

Location

Zurich, Switzerland